Literature DB >> 29284290

Occlusion Detection Time in Insulin Pumps at Two Different Basal Rates.

Guido Freckmann1, Ulrike Kamecke1, Delia Waldenmaier1, Cornelia Haug1, Ralph Ziegler2.   

Abstract

BACKGROUND: The detection of insulin infusion set (IIS) occlusions is an important feature of insulin pumps with regard to patient safety. However, there are no requirements for a time limit until an alarm has to be triggered after an occlusion occurred. The standard IEC 60601-2-24 is applicable for insulin pumps and describes test settings and procedures to determine occlusion detection time (ODT).
METHODS: In this study, ODT of six different insulin pump models with different IIS (in total 10 different insulin pump systems) was tested for two basal rates (1.0 U/h and 0.1 U/h).
RESULTS: Differences were seen between the tested pump systems. At a basal rate of 1.0 U/h all insulin pump systems showed an acceptable ODT of less than 5 hours. However, at a basal rate of 0.1 U/h, as often used in children, the median ODT ranged from approximately 4 hours to more than 40 hours. With the lower basal rate, median ODT was longer than 6-8 hours for 9 of the 10 systems.
CONCLUSIONS: Insulin pump users should not blindly rely on occlusion alarms but perform regular glucose monitoring and manufacturers should develop mechanisms that allow an earlier detection at low basal rates.

Entities:  

Keywords:  CSII; basal rate; children; insulin pump; occlusion

Mesh:

Substances:

Year:  2017        PMID: 29284290      PMCID: PMC6154229          DOI: 10.1177/1932296817750404

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  12 in total

1.  Significant time until catheter occlusion alerts in currently marketed insulin pumps at two basal rates.

Authors:  Arianne C van Bon; Dorien Dragt; J Hans DeVries
Journal:  Diabetes Technol Ther       Date:  2012-05       Impact factor: 6.118

2.  Comparison of human regular and lispro insulins after interruption of continuous subcutaneous insulin infusion and in the treatment of acutely decompensated IDDM.

Authors:  N Attia; T W Jones; J Holcombe; W V Tamborlane
Journal:  Diabetes Care       Date:  1998-05       Impact factor: 19.112

3.  Insulin Pump Occlusions: For Patients Who Have Been Around the (Infusion) Block.

Authors:  David C Klonoff; Guido Freckmann; Lutz Heinemann
Journal:  J Diabetes Sci Technol       Date:  2017-03-30

4.  Accuracy of a new patch pump based on a microelectromechanical system (MEMS) compared to other commercially available insulin pumps: results of the first in vitro and in vivo studies.

Authors:  Sophie Borot; Sylvia Franc; Justine Cristante; Alfred Penfornis; Pierre-Yves Benhamou; Bruno Guerci; Hélène Hanaire; Eric Renard; Yves Reznik; Chantal Simon; Guillaume Charpentier
Journal:  J Diabetes Sci Technol       Date:  2014-07-30

5.  Basal rate subcutaneous insulin infusion: absorption kinetics and relation to local blood flow.

Authors:  P Hildebrandt; K Birch
Journal:  Diabet Med       Date:  1988 Jul-Aug       Impact factor: 4.359

6.  Cessation of insulin infusion at night-time during CSII-therapy: comparison of regular human insulin and insulin lispro.

Authors:  A Reichel; H Rietzsch; H J Köhler; A Pfützner; U Gudat; J Schulze
Journal:  Exp Clin Endocrinol Diabetes       Date:  1998       Impact factor: 2.949

Review 7.  Hyperglycemic crises in adult patients with diabetes.

Authors:  Abbas E Kitabchi; Guillermo E Umpierrez; John M Miles; Joseph N Fisher
Journal:  Diabetes Care       Date:  2009-07       Impact factor: 17.152

8.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

9.  A 2-yr national population study of pediatric ketoacidosis in Sweden: predisposing conditions and insulin pump use.

Authors:  Ragnar Hanas; Fredrik Lindgren; Bengt Lindblad
Journal:  Pediatr Diabetes       Date:  2008-08-21       Impact factor: 4.866

10.  Reduced Silent Occlusions with a Novel Catheter Infusion Set (BD FlowSmart): Results from Two Open-Label Comparative Studies.

Authors:  Michael Gibney; Zhenyi Xue; Monica Swinney; Damian Bialonczyk; Laurence Hirsch
Journal:  Diabetes Technol Ther       Date:  2015-12-24       Impact factor: 6.118

View more
  2 in total

1.  Insulin induces a progressive increase in the resistance of subcutaneous tissue to fluid flow: Implications for insulin pump therapy.

Authors:  Werner Regittnig; Mathias Tschaikner; Alexandru-Cristian Tuca; Amra Simic; Jürgen Feiel; Roland Schaller-Ammann; Alexander H Licht; Miró Jungklaus; Thomas R Pieber
Journal:  Diabetes Obes Metab       Date:  2021-11-17       Impact factor: 6.408

2.  Evaluation of the Accuracy and Reliability of a Tubeless Insulin Infusion System Under Laboratory Conditions.

Authors:  Jochen Mende; Manuel Eichenlaub; Delia Waldenmaier; Cornelia Haug; Guido Freckmann; Ralph Ziegler
Journal:  J Diabetes Sci Technol       Date:  2022-01-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.